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Summary
Background: The regeneration of cardiomyocytes after a myocardial infarction (MI) is more evident in young animals; 
however, it is not known whether it is associated with functional improvement.
Objective: To perform the functional analysis by echocardiography (echo) of young adult rats submitted to MI. 
Methods: Seventy-two animals were included in the study: 35 young rats (group Y) that were 28 days old and 37 adult 
rats (group A) that were 153 days old. The rats were subdivided in two subgroups: infarcted (YI and AI) and control (YC 
and AC). The animals were assessed by echocardiogram on the 7thand 30th postoperative days for the analysis of the 
ejection fraction (EF) and the final systolic (FSV) and diastolic volume (FDV) of the left ventricle. Only animals with EF < 
40% were included in the study.
Results: The comparison of the FDV and FSV between infarcted and control animals showed that there was a significant 
increase in infarcted adult animals at the two analyzed phases. Among young animals only the FSV was significantly 
higher on the 7th day. The intragroup evolution analysis showed an increase in FDV and FSV in the two young subgroups, 
which was proportional to growth and only increase in FDV in the infarcted adult group. There was an improvement in 
EF in young rats, whereas EF remained decreased in adult rats when compared to controls. 
Conclusion: The infarcted young rats presented improvement in the systolic function and ventricular volumes 30 days 
after the infarction, whereas the adult rats presented increased FDV with no improvement in systolic function. (Arq Bras 
Cardiol 2008; 91(5) : 295-300)
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Introduction
The clinical evolution of adult and pediatric patients with 
ventricular dysfunction due to myocardial ischemic disease 
shows to be distinct, as well as its etiologies1,2. Among adults 
with myocardial infarction (MI) submitted to coronary artery 
reperfusion, only a small number of patients presents full 
recovery of the cardiac function; however, in children with 
significant ventricular dysfunction secondary to ischemic 
diseases, a better evolution is observed1-3. The proliferation 
of new cardiomyocytes can be one of the compensation 
mechanisms that needs to be better understood. 
During the gestational phase and for a short time after the 
birth, the growth of cardiomyocytes occurs by hyperplasia and, 
subsequently, by hypertrophy4,5, which can contribute to a better 
recovery in young individuals. Anversa and cols. suggest that the 
cardiomyocytes are constantly renewed, even in adult individuals; 
however, this is not enough for full function recovery6. 
Considering the hypothesis that the heart of young animals 
submitted to myocardial infarction, with significant left ventricle 
dysfunction, presents better recovery of the systolic function, 
this echocardiographic study was designed to compare the 
functional evolution of the heart of young and adult rats 
submitted to surgical ligature of the left coronary artery. 
Methods
The initial study sample consisted of 168 male Wistar rats 
(Rattus Norvegicus Albinus, Rodentia, Mammalia): 98 young rats 
(28 days old) and 70 adult rats (153 days old). The final sample 
consisted of 72 rats, being 35 young and 37 adult animals. 
The young (group Y) and adult (group A) rats were 
subdivided in two subgroups: 1) infracted animals, called YI 
and AI; and 2) controls, called YC and AC. The experimental 
group was submitted to myocardial infarction through surgical 
ligature of the left coronary artery and the control group, to 
sham operation. 
To undergo the surgery and echocardiogram, the animals were 
anesthetized with a basal dose of ketamine (Ketalar®) of 50 mg/kg 
and xylazine (Xylazine®) of 10 mg/kg, intramuscularly. In order 
to ascertain the anesthetic effect, the absence of neuromuscular 
reflex was observed. In young rats, a lower dose of ketamine was 
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used, corresponding, on average, to half the adult dose. 
 For the surgical procedure, the animals were submitted 
to orotracheal intubation and mechanical ventilation, with a 
Harvard 683 volume respirator, with 68 cycles per minute, 
with 21% oxygen. The MI was carried out according to what 
was described by Tarnavski et al7. For the sham operation, the 
same surgical phases were performed, except for the ligature 
of the left coronary artery.
The echocardiographic studies were performed on the 7th 
and the 30th postoperative days. The parasternal longitudinal 
image was used for the planimetry of the left ventricle (LV) by 
the Simpson method to obtain the final diastolic volume (FDV) 
and the final systolic volume (FSV) and the ejection fraction 
(EF) was calculated by the equipment software8. The FDV 
was obtained at the R wave peak of the electrocardiogram 
and the FSV, at the smallest LV diameter, both aided by the 
visualization of the closed mitral and aortic valves.
The volumes were measured in three consecutive cardiac 
cycles and after that, the arithmetic mean of these values was 
calculated. The myocardial infarction was established based 
on the longitudinal and transversal images of the LV.
The left ventricular dysfunction was characterized by the 
presence of EF < 40% at the echocardiogram on the 7th 
postoperative day. Therefore, the rats from the infarcted group 
that presented EF> 40% were excluded from the analysis.
The assessments and measurements were carried out in an 
Agilent echocardiogram equipment (model Sonos 5500; Andover, 
MA), equipped with S12 MHz and L15 MHz transducers, model 
21390A, Agilent, Palo Alto, CA. The equipment has the capacity 
of 120 pictures per second (Hertz). 
Some animals were randomized for euthanization during 
the study. 
All animals received humane care throughout the study 
in accordance with the “Guiding Principles for the Care and 
Use of Laboratory Animals in Research”, following the “Ethical 
Principles in Animal Experimentation of the Brazilian College 
of Animal Experimentation” (Cobea). The study was approved 
by the Ethics Committee in Animal Research of the Pontificia 
Universidade Catolica do Paraná.
The statistical analysis was carried out with the software 
Statistica v.10. The results were expressed as means and 
standard deviations. The Student’s t test was used to compare 
the study and the control groups for independent samples, 
considering the homogeneity of the variances. To compare 
the moments of evaluation, the Student’s t test was used for 
dependent samples. 
The condition of data normality was evaluated by the Shapiro-
Wilks test and the condition of homogeneity of the variances 
was evaluated by Levene’s test. The level of significance was set 
at 0.05, adjusted with Bonferroni correction. Thus, p values < 
0.025 indicated statistically significant differences. 
Results
The mortality rate of the study was 34.5%. In the infarcted 
subgroups, 18 young rats (33.9%) and 8 (17.3%) adult rats 
were excluded, as they presented EF > 40% on the 7th 
postoperative day, as well as 12 rats with identification 
problems. The final sample consisted of 72 rats, being 35 
young and 37 adult animals.
The mean weight of the young animals in the beginning of 
the study was 186.4 ± 35.5 g, with no difference between 
the subgroups (YI and YC). There was a significant difference 
in weight on the 30th day echocardiogram, with p< 0.01, with 
values of 265.3 ± 8.7 g for YI and 312.3 ± 17.4 g for YC. 
In the adult group there was no difference in weight 
between the subgroups at the two analyzed moments, as 
well as in the comparison of evolution in the subgroups. The 
animals’ mean weight on the 7th postoperative day was  343.4 
± 24.4 g and 364.2 ± 22.4 g on the 30th day. 
The heart rate (HR) of the young animals was 270 ± 66 
bpm on the 7th day and  203 ± 36 bpm on the 30th day, and 
in the adult group, it was  204 ± 27 and 191 ± 27 bpm, on 
the 7th and 30th days, respectively.  There was no statistical 
difference in the comparison between the infarcted and 
control animals of the same group at the two analyzed periods 
as well as during the evolution in the same subgroups. 
The mean FDV in the young rats of the infarcted subgroup 
was similar to that of the control subgroup, in the two analyzed 
periods. The FSV was significantly higher in the infarcted 
subgroup, when compared to the control subgroup on the 
7th postoperative day (p < 0.01); consequently, the ejection 
fraction was significantly decreased in this period (Table 1).
Table 1 – Distribution and comparison of the echocardiographic variables in the young rat group
 n Infarcted n Controls P*
FDV* (ml)
7 days 22 0.371 ± 0.179 13 0.404 ± 0.060 0.441
30 days 14 0.557 ± 0.148 9 0.626 ± 0.146 0.286
FSV* (ml)
7 days 22 0.270 ± 0.143 13 0.169 ± 0.041 0.004
30 days 14 0.347 ± 0.160 9 0.325 ± 0.072 0.665
EF* (%)
7 days 22 27.9 ± 7.6 13 58.6 ± 6.7 < 0.001
30 days 14 40.6 ± 13.2 9 47.7 ± 4.2 0.079
FDV - final diastolic volume in milliliters; FSV - final systolic volume in milliliters; EF - percentage of ejection fraction; (*)Student t Test for independent samples 
(p < 0.025, Bonferroni correction); FDV - final diastolic volume; FSV - final systolic volume; EF - ejection fraction; (*)Student t Test for independent samples (p 
< 0.025, Bonferroni correction)
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Table 2 – Comparison of the echocardiographic values at the evolution with paired samples, of 7 and 30 days, in the young rat group 
n 7 30 p*
FDV (ml)
infarcted 14 0.290 ± 0.152 0.557 ± 0.148 <0.001
controls 9 0.418 ± 0.059 0.626 ±0.146 0.006
FSV (ml)
infarcted 14 0.210 ± 0.122 0.347 ± 0.160 <0.001
controls 9 0.169 ± 0.048 0.325 ± 0.071 0.001
EF (%)
infarcted 14 28.1 ± 8.8 40.6 ± 13.2 0.001
controls 9 60.3 ± 6.7 47.7 ± 4.2 0.001
FDV - final diastolic volume; FSV - final systolic volume; EF - ejection fraction; (*)Student t Test for independent samples (p < 0.025, Bonferroni correction); FDV 
- final diastolic volume in milliliters; FSV - final systolic volume in milliliters; EF - percentage of ejection fraction; (*)Student t Test for independent samples (p < 
0.025, Bonferroni correction)
The analysis of evolution of the young animals carried out 
with the paired sample, showed a significant increase in the 
FDV and the FSV between the 7th and 30th postoperative days, 
associated with the animals’ growth. The ejection fraction 
of the infarcted subgroup increased significantly (p < 0.01), 
whereas there was a significant decrease in the control group, 
p < 0.01 (Table 2). 
The comparison between the infarcted and control subgroups 
of the adult animal group showed that the FDV on the 30th day 
and the FSV on the 7th and 30th days were significantly higher 
in the infarcted subgroup, with p < 0.05, p < 0.001 and p < 
0.01, respectively. The EF was significantly decreased in the two 
analyzed phases, with p < 0.001 and p < 0.001 (Table 3).
The evolution analysis showed that, in the adult rats, only 
the FDV of the infarcted subgroup increased significantly (p 
< 0.01) (Table 4).
Table 3 – Distribution and comparison of the echocardiographic variables in the adult rat group 
 n infarcted n Controls P
FDV* (ml)
7 days 24 0.802 ± 0.112 13 0.724 ± 0.169 0.103
30 days 15 0.919 ± 0.196 10 0.712 ± 0.173 0.013
FSV* (ml)
7 days 24 0.588 ± 0.113 13 0.407 ± 0.131 < 0.001
30 days 15 0.668 ± 0.225 10 0.401 ± 0.111 0.001
EF* (%)
7 days 24 26.9 ± 6.6 13 44.6 ± 7.4 < 0.001
30 days 15 29.0 ± 10.4 10 45.8 ± 4.1 < 0.001
FDV - final diastolic volume; FSV - final systolic volume; EF - ejection fraction; (*)Student t Test for independent samples (p < 0.025, Bonferroni correction)
Table 4 – Comparison of the echocardiographic values at the evolution with paired samples, of 7 and 30 days, in the adult rat group 
n 7 30 p
FDV infarcted 15 0.796 ± 0.107 0.919 ± 0.196 0.009
controls 10 0.667 ± 0.133 0.695 ± 0.168 0.410
FSV
infarcted 15 0.587 ± 0.117 0.668 ± 0.225 0.114
controls 10 0.367 ± 0.110 0.389 ± 0.106 0.305
EF
infarcted 15 26.5 ± 7.5 28.9 ± 10.3 0.369
controls 10 45.7 ± 7.9 46.1 ± 3.7 0.826
FDV - final diastolic volume in milliliters; FSV - final systolic volume in milliliters; EF - percentage of ejection fraction; (*)Student t Test for independent samples (p < 0.025, 
Bonferroni correction)
When comparing the two infarcted subgroups, the FDV on 
the 7th day (YI 0.371 ± 0.179 ml and AI 0.802 ± 0.112 ml) 
and on the 30th day (YI 0.557 ± 0.148 ml and AI 0.919 ± 
0.196 ml), was significantly different, with p < 0.001 in the 
analyzed periods.  The same statistical difference was observed 
when comparing the FSV on the 7th day (YI 0.270 ± 0.143 
ml and AI 0.588 ± 0.113 ml) and on the 30th day (YI 0.347 
± 0.160 ml and AI 0.668 ± 0.225 ml).
When comparing the EF, no significant difference was 
observed between the two infarcted groups on the 7th 
postoperative day. On the 30th postoperative day, there was 
a marked improvement in the young subgroup, whereas the 
EF remained unaltered in adult group (p = 0.013). 
The young infarcted subgroup attained the normal 
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It was observed in the present study that the heart of the 
young infarcted rat showed a significant recovery of the systolic 
cardiac function when compared to the adult rat heart. The 
28-day-old rats, considered young, reached, at the end of the 
study, a weight and cardiac development that was similar to 
that of the adult rats that started the study at 153 days old. 
During the echocardiographic study, the heart rate of the 
animals was monitored with an echocardiographic tracing. On 
the 7th postoperative day, the number of beats was significantly 
higher in the group of young rats; however, on the 30th 
postoperative day, the numbers were similar. 
As the animals were anesthetized, the heart rate was not 
the actual one, considering that the association of xylazine 
and ketamine produces bradycardia9,10. However, the mean 
values obtained in the adult rats were similar to those of other 
studies that used the same anesthetics9. The smallest dose used 
in the young rats can be the cause of the higher HR in these 
animals on the 7th postoperative day; however, this procedure 
was essential for the carrying out of the study, considering that 
many of young rats died at the beginning of the experiment, 
when there was an attempt to use the suggested total dose.
The general mortality of the study is similar to that reported 
by other authors. However, the mortality in the young group, 
alone, was the highest (49.3%)11. Additionally, the induction 
of significant infarction was more difficult in the young rats; 
therefore, the exclusion from the study due to an EF > 40% 
was higher in this group. 
As the extension of the infarction cannot be controlled, the 
Simpson method was used for the echocardiographic analysis 
of the EF in the present study, as it allows the deformed area 
of the left ventricle to be included in the calculation of the 
systolic and diastolic volumes8,12,13.
The LV final diastolic volume in the adult rat was increased 
when compared to that of the non-infarcted pairs. This 
alteration occurs as a consequence of the loss of contractile 
elements and the normal architecture of the ventricular wall, 
with a decrease in the contractile capacity of the affected 
region and, consequently, systolic function impairment13,14.
The ventricular dilation is one of the compensatory 
mechanisms to maintain the cardiac output and it is related 
to ventricular remodeling14,15. The increase in ventricular 
diameter results in higher ventricular wall stress and triggers 
compensatory mechanisms such as hypertrophy and 
hyperplasia14,16,17.
In young rats, the FDV was similar between infarcted and 
control animals. This evolution was different in the group of 
adult rats, as the infarcted rats presented significantly higher 
values than the control animals on the 30th postoperative day. 
This fact is probably due to compensatory mechanisms such 
as hyperplasia and hypertrophy and to the lower infarction 
expansion, which are more evident in young animals and 
might have had an effect on the smaller dilation of the 
ventricular cavity13,18,19.
The non-dilation of the ventricular cavity on the 7th day 
might be due to the hypertrophy and increased capacity of 
contraction of the non-infarcted areas. 
The study by Litwin et al13 showed that two infarcted rats 
presented smaller volumes than their controls among 11 
observed animals, although the cause of this finding was not 
reported. This same fact occurred among the young rats, but 
with no statistical significance. 
The final systolic volume in the young infarcted group was 
significantly higher than that of the control group on the 7th 
postoperative day and did not show any statistical difference 
on the 30th day. The hindering of the systolic dilation can also 
be due to mechanisms of hyperplasia, hypertrophy and lower 
infarction expansion in this age range20.
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The ejection fraction values established for this study 
are lower than the ones used by other authors19,21, as the 
objective was that the animals would have not only myocardial 
infarction, but also ventricular dysfunction. 
A cutoff of 40% for the EF showed to be adequate, as the 
rats with EF<40% on the 7th postoperative day presented 
significant infarction. Moreover, no control rat had an EF < 
40%.
The EF in the infarcted adult rats showed to be significantly 
lower in the two analyzed periods. In the young group, 
however, there was an increase during the evolution, which 
was close to the values presented by the young controls. The 
differentiated capacity of cell proliferation and hypertrophy 
in the hearts of young rats might be one of the mechanisms 
of contractility recovery of these animals22.
The regeneration of the cardiac muscle remains controversial, 
even with evidence of the formation of new cardiomyocytes 
in the adult heart. Thus, the persistence of a low EF in 
infarcted adult rats probably occurred due to the inadequate 
compensatory hypertrophy of the non-infarcted areas and by 
the lower rate of cardiomyocyte replacement16,22.
The worsening in the cardiac function may also be due 
to the myocardial contractility depression in regions distant 
from the infarction13,23,24. It is suggested that, in the adult 
rats with myocardial hypertrophy, a disproportion between 
the development of new capillaries and the myocardial 
hypertrophy occurs. This anatomical alteration might be related 
to the depression of the contractile function of cardiomyocytes 
due to the longer distance for oxygen diffusion25.
The pathological anatomy of an experimental model of 
myocardial infarction showed that the younger rat presented 
a higher capacity of cardiac cell replication when compared 
to the adult rat26. Gould et al27 observed that the 2-month-
old animals presented a better recovery than the 10- and 
12-month-old animals.
The cardiomyocytes are constantly renewed to replace 
the losses caused by death and apoptosis. Studies have 
demonstrated that the adult heart contains a small 
cardiomyocyte population with proliferation capacity, but 
that is not enough to replace the number of cardiomyocytes 
lost at the infarction. The poorer replacement rate in older 
animals could explain the higher tendency to present heart 
failure in adverse situations28,29.
Younger rats present a higher protein synthesis activity, 
necessary for the progression of the cell cycle and replication of 
cardiomyocytes; the myocardial infarction can be the stimulus 
for the cardiomyocyte to re-enter the cell cycle6,22.
Study limitations
The echocardiogram was chosen as it is a non-invasive 
method of assessment of cardiac parameters, which allows the 
heart to be analyzed in series. In rats, however, this procedure 
has limitations, considering that it requires anesthesia, with 
risk for the animal. Additionally, the visualization of all cuts is 
not always possible.  
In the group of young control rats, a decrease in the ejection 
fraction was observed at the evolution. It is known that the use 
of ketamine associated to xylazine, in addition to interfering 
with HR, significantly decreases the parameters of cardiac 
contractility30. The use of a lower drug dose in this group on 
the 7th day of postoperative evolution might have resulted in 
this difference. However, these differences do not modify the 
final study outcome, as the young infarcted subgroup received 
the same treatment during the procedures and on the 30th day, 
all were anesthetized, as the adult rats.
 In conclusion, the adaptive processes of myocardial 
infarction remain to be further understood. 
The present study shows that the myocardial infarction in 
the young rat shows a better recovery of the cardiac function 
than in the adult rat. Further studies, however, are necessary 
to verify whether the functional improvement in young rats 
is accompanied by cell recovery. 
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